Abstract:Background and purpose: N-Myc down stream-regulated gene 2 (NDRG2) is a new type of tumor suppressor gene, which plays an important role in cell proliferation and apoptosis. The chemotherapy resistance of bladder cancer is the main cause for the failure of clinical treatment; therefore, this study aimed to clarify the expression of NDRG2 and its potential role in the pathogenesis of cisplatin (CDDP) resistance in bladder cancer cells. Methods: Bladder cancer T24 cells were continuously passaged by increasing the CDDP concentration for 6 months to obtain CDDP-resistant T24/CR cell lines. Lentiviral transfection was used to achieve high expression of NDRG2 in T24/CR. Cell viability was measured by MTT, apoptosis and transwell invasion assay were performed. The effect of NDRG2 overexpression on T24 cell resistance to CDDP was compared. Bcl-2-siRNA transient transfection was used to knock down the expression of NDRG2 in T24 cells, and then the expression in different groups was detected by Western blot. Real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was used to detect the expression level of NDRG2 mRNA. Results: The expression level of NDRG2 was significantly down-regulated in CDDP-resistant bladder cancer cells. Exogenous overexpression of NDRG2 enhanced the sensitivity to CDDP and inhibited the viability and invasion of bladder cancer cells in the presence of CDDP. Knockdown of NDRG2 expression had no significant effect on the expression of Bcl-2. Knockdown of Bcl-2 could effectively eliminate the effect of low NDRG2 expression on the viability and apoptosis of bladder cancer cells, and could restore the sensitivity to CDDP in bladder cancer cells. Conclusion: The unbalance of NDRG2/Bcl-2 maybe the key mechanism of CDDP resistance in advanced bladder cancer. Enhanced expression of NDRG2 might be used as a candidate for the treatment of CDDP-resistant or refractory bladder cancer.

NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498

Abstract #1989: Down-regulation of Neuropilin-2 Suppresses in Vivo Growth of Gastric Cancer and Sensitizes Cells to 5Fu-Induced Apoptosis

Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Expression of NDRG2 in Clear Cell Renal Cell Carcinoma.

Adenovirus-mediated NDRG2 Inhibits the Proliferation of Human Renal Cell Carcinoma Cell Line OS-RC-2 in Vitro

Influence of NDRG2 on proliferation and apoptosis of human esophageal cell line Eca-109

NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.

Effect of NDRG2 on proliferation of breast cancer cells

NDRG2 Acts As a Negative Regulator Downstream of Androgen Receptor and Inhibits the Growth of Androgen-Dependent and Castration-Resistant Prostate Cancer

Up-Regulation Of Pvhl Along With Down-Regulation Of Hif-L Alpha By Ndrg2 Expression Attenuates Proliferation And Invasion In Renal Cancer Cells

Suppression of Invasion and Metastasis of Prostate Cancer Cells by Overexpression of NDRG2 Gene.

NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade

Knockdown of NDRG1 Promote Epithelial-Mesenchymal Transition of Colorectal Cancer Via NF-κB Signaling.

Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells in Vitro and in Vivo

NDRG2 increases bladder cancer cell sensitivity to cisplatin by inhibiting Bcl-2 expression

Antitumor Effect of Recombinant NDRG2 Protein on Tumor Cells

N-Myc Downstream-Regulated Gene 2 (NDRG2) As a Novel Tumor Suppressor in Multiple Human Cancers

Ndrg2 Inhibits Hepatocellular Carcinoma Adhesion, Migration and Invasion by Regulating Cd24 Expression

N-myc Downstream-Regulated Gene 1 Inhibits the Proliferation of Colorectal Cancer Through Emulative Antagonizing NEDD4-mediated Ubiquitylation of P21

NDRG2 Inhibits Pyruvate Carboxylase-Mediated Anaplerosis and Combines with Glutamine Blockade to Inhibit the Proliferation of Glioma Cells.